EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial Activity, Preliminary Safety, and Pharmacokinetics Assessment of 2–3: A Pleuromutilin-Derived Compound

Feifei Zhao, Yizhen Zhu, Lingxiang Mao, Honghao Huang, Wei Wei, Qiangcheng Deng, Youzhi Tang iD, Ning Han, Zhenling Zeng iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.5c00727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Feifei Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricu…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Diterpenes, Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsDiterpenesStaphylococcus aureusStaphylococcal InfectionsAnimalsPleuromutilinsPolycyclic CompoundsMiceRatsMicrobial Sensitivity TestsMolecular Docking SimulationHumansMaleRats, Sprague-DawleyFemale

Stichwörter der Autor:innen

antimicrobial activitycompound 2−3metabolitepharmacokineticspleuromutilin derivativesafety

Substanzen

PleuromutilinsAnti-Bacterial AgentsDiterpenesPolycyclic Compounds

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
  • National Laboratory of Safety Evaluation (Environmental Assessment) of Veterinary Drugs, South China Agricultural University, Guangzhou 510642, China.
  • China National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou 510642, China.

ORCID-Profile: Youzhi Tang, Zhenling Zeng

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Zhao, F., Zhu, Y., Mao, L., Huang, H., Wei, W., Deng, Q., Tang, Y., Han, N., & Zeng, Z. (2025). Antimicrobial Activity, Preliminary Safety, and Pharmacokinetics Assessment of 2–3: A Pleuromutilin-Derived Compound. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00727

Vancouver

Zhao F, Zhu Y, Mao L, Huang H, Wei W, Deng Q, et al. Antimicrobial Activity, Preliminary Safety, and Pharmacokinetics Assessment of 2–3: A Pleuromutilin-Derived Compound. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00727

BibTeX
@article{Zhao2025,
  author = {Zhao, Feifei and Zhu, Yizhen and Mao, Lingxiang and Huang, Honghao and Wei, Wei and Deng, Qiangcheng and Tang, Youzhi and Han, Ning and Zeng, Zhenling},
  title = {Antimicrobial Activity, Preliminary Safety, and Pharmacokinetics Assessment of 2–3: A Pleuromutilin-Derived Compound},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.5c00727}
}
Kostenlos starten →